ReleaseWire

Bruce Rippe CEO of Trinity Guardion and Edmond A. Hooker, MD, DrPH Discuss Medical Mattress Contamination Issues on C.diff. Spores and More on April 10

Posted: Monday, April 09, 2018 at 11:00 AM CDT

Phoenix, AZ -- (SBWire) -- 04/09/2018 --C Diff Foundation's, "C. diff. Spores and More," is honored to announce Bruce Rippe, CEO of Trinity Guardion, manufacturer of the Trinity Guardion Patient Protective Barrier, and Edmond Hooker,MD, DrP, Associate Professor of Health Services Administration at Xavier University, as our guest speakers on April 10th , 2018 at 10:00 a.m. PT / 1:00 p.m. ET on http://www.cdiffradio.com.

These leading topic experts will be discussing Dr. Hooker's Clostridium difficile (C. diff.) research related to hospital beds and mattresses, the issues that prevent successful disinfection of soft mattress surfaces, the new regulatory landscape, and the proven solution to the problem. The data being shared will be beneficial to hospital nursing officers, infection preventionists, and environmental services professionals. Many healthcare professionals are unaware that hospital beds, which are the epicenter of patient care, can also be the epicenter of potentially life-threatening cross-contamination.

Trinity Guardion's patient protective microbarrier is the first and only launderable and reusable mattress cover system specifically for medical beds. It's designed to protect each patient and prolong the useful life of expensive high-tech hospital mattresses, by shielding the mattress and bed deck from every previous occupant's microbial biome. More importantly, it protects each patient from residual pathogenic organisms such as C. diff., which can cause serious illness and death, and may be present even if previous patients were not symptomatic.

About Trinity Guardion
Founded in 2010 and based in Batesville, IN, Trinity Guardion manufactures the Trinity GuardionĀ® Patient Protective Barrier, the only reusable and launderable cover system for hospital beds and bed decks that is specifically engineered to block and eliminate pathogens such as Clostridium difficile (C. diff.). The system delivers a validated cleaning and disinfection solution that is proven to reduce infection rates.

About The C Diff Foundation
The C Diff Foundation, a 501(c)3 non-profit, founded in 2012 by a Nurse and three time C.diff Survivor who recognized the need for greater awareness through education, and research being conducted by the government, industry, and academia with better advocacy on behalf of patients, healthcare professionals, and researchers worldwide working to address the public health threat posed by this life-threatening infection.

For information please visit http://www.cdifffoundation.org/.

Media Coordinator
Angelo Ortiz
angelo.ortiz@cdifffoundation.org